AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced that it has scheduled a conference call with management for Monday, Aug. 6 at 4:30 p.m. ET.
In addition to reviewing second quarter financials and pipeline progress, Introgen management will address questions about its programs in light of recent developments in the gene therapy space.
